Home/Nuevocor/Khoo Shih, PhD

KS

Khoo Shih, PhD

Board Member

Therapeutic Areas

Cardiovascular Genetic Cardiomyopathy

Nuevocor Pipeline

Drug	Indication	Phase
NVC-001A	LMNA-related Dilated Cardiomyopathy	Phase 1
NVC-001B	Undisclosed	Preclinical
NVC-002	Undisclosed	Preclinical

Leadership Team at Nuevocor

Albert Gianchetti

Chief Executive Officer

Vice President, Clinical Operations

Vice President, Operations

Nicolas Guyon-Gellin, MD

Chief Business Officer

Christian Beck, PhD

Vice President, Corporate Development

Andreas Wallnoefer, PhD, MBA

Thierry Abribat, PhD

Elia Stupka, PhD

Amanda Gett-Chaperot, PhD, MBA

View full Nuevocor profile